Aryl hydrocarbon receptor downregulates MYCN expression and promotes cell differentiation of neuroblastoma

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Wu, Pei Yi ^a   Liao, Yung Feng ^a,b   Juan, Hsueh Fen ^a   Huang, Hsuan Cheng ^c   Wang, Bo Jeng ^b   Lu, Yen Lin ^a   Yu, I Shing ^d   Shih, Yu Yin ^b   Jeng, Yung Ming ^e   Hsu, Wen Ming ^e   Lee, Hsinyu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; SHORT HAIRPIN RNA; LUCIFERASE; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; OLIGONUCLEOTIDE; ONCOPROTEIN; PRIMER DNA;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; GENE AMPLIFICATION; GENE CONTROL; GENE DOSAGE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MYCN GENE; NEUROBLASTOMA; ONCOGENE; SIGNAL TRANSDUCTION; BIOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TISSUE MICROARRAY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; NEUROBLASTOMA; NUCLEAR PROTEINS; OLIGONUCLEOTIDES; ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STATISTICS, NONPARAMETRIC; TISSUE ARRAY ANALYSIS;

EID: 84896132280     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088795     Document Type: Article

References (49)

1. Maris JM, Matthay KK (1999) Molecular biology of neuroblastoma. J Clin Oncol 17: 2264-2279. (Pubitemid 29318861)
2. Nishihira H, Toyoda Y, Tanaka Y, Ijiri R, Aida N, et al. (2000) Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution. J Clin Oncol 18: 3012-3017. (Pubitemid 30644126)
3. Pritchard J, Hickman JA (1994) Why does stage 4s neuroblastoma regress spontaneously? Lancet 344: 869-870. (Pubitemid 24290390)
4. Ijiri R, Tanaka Y, Kato K, Misugi K, Nishihira H, et al. (2000) Clinicopathologic study of mass-screened neuroblastoma with special emphasis on untreated observed cases: a possible histologic clue to tumor regression. Am J Surg Pathol 24: 807-815. (Pubitemid 30366267)
5. Tonini GP (1993) Neuroblastoma: the result of multistep transformation? Stem Cells 11: 276-282.
6. Hoehner JC, Gestblom C, Hedborg F, Sandstedt B, Olsen L, et al. (1996) A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab Invest 75: 659-675. (Pubitemid 26392797)
7. Israel MA (1993) Disordered differentiation as a target for novel approaches to the treatment of neuroblastoma. Cancer 71: 3310-3313. (Pubitemid 23148517)
8. Cooper MJ, Steinberg SM, Chatten J, Evans AE, Israel MA (1992) Plasticity of neuroblastoma tumor cells to differentiate along a fetal adrenal ganglionic lineage predicts for improved patient survival. J Clin Invest 90: 2402-2408. (Pubitemid 23010059)
9. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, et al. (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328: 847-854. (Pubitemid 23084339)
10. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
11. Cohn SL, Tweddle DA (2004) MYCN amplification remains prognostically strong 20 years after its "clinical debut". European Journal of Cancer 40: 2639-2642. (Pubitemid 39574716)
12. Norris MD, Burkhart CA, Marshall GM, Weiss WA, Haber M (2000) Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model. Med Pediatr Oncol 35: 585-589.
13. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL, et al. (1996) Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. New England Journal of Medicine 334: 231-238. (Pubitemid 26032215)
14. Brodeur GM (1995) Molecular basis for heterogeneity in human neuroblastomas. Eur J Cancer 31A: 505-510.
15. FernandezSalguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ (1996) Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8- tetrachlorodi-benzo-p-dioxin-induced toxicity. Toxicology and Applied Pharmacology 140: 173-179.
16. Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, et al. (1997) Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes to Cells 2: 645-654. (Pubitemid 127688610)
17. Marlowe JL, Fan YX, Chang XQ, Peng L, Knudsen ES, et al. (2008) The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Molecular Biology of the Cell 19: 3263-3271.
18. Marlowe JL, Knudsen ES, Schwemberger S, Puga A (2004) The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. Journal of Biological Chemistry 279: 29013-29022. (Pubitemid 38915771)
19. Puga A, Barnes SJ, Dalton TP, Chang CY, Knudsen ES, et al. (2000) Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. Journal of Biological Chemistry 275: 2943-2950. (Pubitemid 30082071)
20. Watabe Y, Nazuka N, Tezuka M, Shimba S (2010) Aryl Hydrocarbon Receptor Functions as a Potent Coactivator of E2F1-Dependent Trascription Activity. Biological & Pharmaceutical Bulletin 33: 389-397.
21. Akahoshi E, Yoshimura S, Ishihara-Sugano M (2006) Over-expression of AhR (aryl hydrocarbon receptor) induces neural differentiation of Neuro2a cells: neurotoxicology study. Environ Health 5: 24.
22. Jin DQ, Jung JW, Lee YS, Kim JA (2004) 2,3,7,8-Tetrachlorodibenzo-p- dioxin inhibits cell proliferation through arylhydrocarbon receptor-mediated G1 arrest in SK-N-SH human neuronal cells. Neurosci Lett 363: 69-72. (Pubitemid 38639854)
23. Qin H, Powell-Coffman JA (2004) The Caenorhabditis elegans aryl hydrocarbon receptor, AHR-1, regulates neuronal development. Dev Biol 270: 64-75. (Pubitemid 38596929)
24. Shimada H (2003) The International Neuroblastoma Pathology Classification. Pathologica 95: 240-241.
25. Kopf I, Hanson C, Delle U, Verbiene I, Weimarck A (1996) A rapid and simplified technique for analysis of archival formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization (FISH). Anticancer Research 16: 2533-2536. (Pubitemid 26388213)
26. Tajiri T, Shono K, Fujii Y, Noguchi S, Kinoshita Y, et al. (1999) Highly sensitive analysis for N-myc amplification in neuroblastoma based on fluorescence in situ hybridization. Journal of Pediatric Surgery 34: 1615-1619.
27. Cheng KC, Huang HC, Chen JH, Hsu JW, Cheng HC, et al. (2007) Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network construction. BMC Genomics 8: 411.
28. Tseng CW, Huang HC, Shih AC, Chang YY, Hsu CC, et al. (2012) Revealing the Anti-Tumor Effect of Artificial miRNA p-27-5p on Human Breast Carcinoma Cell Line T-47D. Int J Mol Sci 13: 6352-6369.
29. Kramer A, Green J, Pollard J, Jr., Tugendreich S (2013) Causal Analysis Approaches in Ingenuity Pathway Analysis (IPA). Bioinformatics.
30. Lutz W, Stohr M, Schurmann J, Wenzel A, Lohr A, et al. (1996) Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene 13: 803-812. (Pubitemid 26312908)
31. Ossewaarde JM, de Vries A, Bestebroer T, Angulo AF (1996) Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplas-ma-infected Chlamydia sp. strains. Appl Environ Microbiol 62: 328-331.
32. Ohira M, Oba S, Nakamura Y, Isogai E, Kaneko S, et al. (2005) Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas. Cancer Cell 7: 337-350. (Pubitemid 40544651)
33. Brodeur GM (2003) Neuroblastoma: Biological insights into a clinical enigma. Nature Reviews Cancer 3: 203-216.
34. Collins LL, Williamson MA, Thompson BD, Dever DP, Gasiewicz TA, et al. (2008) 2,3,7,8-Tetracholorodibenzo-p-Dioxin Exposure Disrupts Granule Neuron Precursor Maturation in the Developing Mouse Cerebellum. Toxicological Sciences 103: 125-136. (Pubitemid 351524484)
35. Latchney SE, Hein AM, O'Banion MK, DiCicco-Bloom E, Opanashuk LA (2013) Deletion or activation of the aryl hydrocarbon receptor alters adult hippocampal neurogenesis and contextual fear memory. Journal of Neuro-chemistry 125: 430-445.
36. Huang T-C, Chang H-Y, Chen C-Y, Wu P-Y, Lee H, et al. (2011) Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR. FEBS Letters 585: 3582-3586.
37. Peverali FA, Orioli D, Tonon L, Ciana P, Bunone G, et al. (1996) Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions. Oncogene 12: 457-462. (Pubitemid 26042583)
38. Janardhanan R, Banik NL, Ray SK (2009) N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53. Biochemical Pharmacology 78: 1105-1114.
39. Manz A, Berger J, Dwyer JH, Fleschjanys D, Nagel S, et al. (1991) Cancer Mortality Among Workers in Chemical-Plant Contaminated with Dioxin. Lancet 338: 959-964.
40. Fingerhut MA, Halperin WE, Marlow DA, Piacitelli LA, Honchar PA, et al. (1991) Cancer Mortality in Workers Exposed to 2,3,7,8-Tetrachlorodibenzo-Para- Dioxin. New England Journal of Medicine 324: 212-218.
41. Fleschjanys D, Berger J, Gurn P, Manz A, Nagel S, et al. (1995) Exposure to Polychlorinated Dioxins and Furans (Pcdd/F) and Mortality in a Cohort of Workers From a Herbicide-Producing Plant in Hamburg, Federal-Republic-of- Germany. American Journal of Epidemiology 142: 1165-1175.
42. Bertazzi PA (1991) Long-Term Effects of Chemical Disasters - Lessons and Results from Seveso. Science of the Total Environment 106: 5-20.
43. Sommer RJ, Sojka KM, Pollenz RS, Cooke PS, Peterson RE (1999) Ah receptor and ARNT protein and mRNA concentrations in rat prostate: Effects of stage of development and 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. Toxicology and Applied Pharmacology 155: 177-189. (Pubitemid 29122840)
44. Kerr MA, Nasca PC, Mundt KA, Michalek AM (2000) Parental occupational exposures and risk of neuroblastoma: a case-control study (United States). Cancer Causes & Control 11: 635-643. (Pubitemid 30636363)
45. Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes & Development 12: 2245-2262.
46. Harbour JW, Dean DC (2000) Rb function in cell-cycle regulation and apoptosis. Nature Cell Biology 2: E65-E67.
47. Shimba S, Komiyama K, Moro I, Tezuka M (2002) Overexpression of the aryl hydrocarbon receptor (AhR) accelerates the cell proliferation of A549 cells. Journal of Biochemistry 132: 795-802. (Pubitemid 35408504)
48. Trimarchi JM, Lees JA (2002) Sibling rivalry in the E2F family. Nature Reviews Molecular Cell Biology 3: 11-20. (Pubitemid 135709914)
49. Strieder V, Lutz W (2003) E2F proteins regulate MYCN expression in neuroblastomas. Journal of Biological Chemistry 278: 2983-2989. (Pubitemid 36801205)